A2 Vertaisarvioitu katsausartikkeli tieteellisessä lehdessä

New opportunities for nuclear cardiology with total-body positron emission tomography/computed tomography




TekijätSaraste, Antti; Knuuti, Juhani

KustantajaElsevier BV

Julkaisuvuosi2026

Lehti: Journal of Nuclear Cardiology

Artikkelin numero102652

ISSN1071-3581

eISSN1532-6551

DOIhttps://doi.org/10.1016/j.nuclcard.2026.102652

Julkaisun avoimuus kirjaamishetkelläAvoimesti saatavilla

Julkaisukanavan avoimuus Osittain avoin julkaisukanava

Verkko-osoitehttps://doi.org/10.1016/j.nuclcard.2026.102652

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/515628897

Rinnakkaistallenteen lisenssiCC BY

Rinnakkaistallennetun julkaisun versioKustantajan versio


Tiivistelmä
Total-body positron emission tomography (PET) systems with a long axial field of view (LAFOV) are now commercially available and represent the state of the art in PET imaging. These systems provide wide anatomical coverage and markedly increased detection sensitivity. Clinical studies have demonstrated enhanced image quality, superior quantification, and benefits for tracer kinetic modeling through dynamic imaging. LAFOV PET/CT allows for substantial reductions in acquisition time and radiation dose while maintaining diagnostic image quality. Full-body coverage enables dynamic whole-body imaging, which enables tracer kinetic modeling across multiple organs and the large vascular structures, offering new opportunities for studying their interactions in cardiovascular and systemic diseases. Furthermore, these systems facilitate the development of new PET methods including pharmacokinetics of new tracers. This review discusses the emerging opportunities and challenges associated with the application of LAFOV PET/CT systems in cardiovascular diseases.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Julkaisussa olevat rahoitustiedot
Funding from the Jane and Aatos Erkko Foundation, the Finnish Foundation for Cardiovascular Research, Finnish State Research Funding, the Research Council of Finland (343152), and InFLAMES research flagship of the Research Council of Finland (337530 and 357910).


Last updated on